Calnan Michael, Wainwright David, Glasner Peter, Newbury-Ecob Ruth, Ferlie Ewan
MRC HSRC Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol, BS8 2PR, UK.
Med Health Care Philos. 2006;9(1):33-41. doi: 10.1007/s11019-005-7496-2.
There is considerable uncertainty about the implications of the new genetics for health services. These are the enthusiasts who argue that molecular genetics will transform health care and others argue that the scope for genetic interventions is limited. The aim of this paper is to examine some of the questions, tensions and difficulties which face health care providers particularly in developed countries as they try to come to terms with the dilemmas raised by new genetic health care technologies (NGHTs). It identifies questions for research which may help the development of robust and flexible strategies for implementation.
新遗传学对医疗服务的影响存在很大的不确定性。一些热心者认为分子遗传学将变革医疗保健,而另一些人则认为基因干预的范围有限。本文旨在探讨医疗服务提供者,尤其是发达国家的医疗服务提供者在试图应对新基因医疗技术(NGHTs)带来的困境时所面临的一些问题、矛盾和困难。它提出了一些研究问题,这些问题可能有助于制定强有力且灵活的实施策略。